Skip to main content

Please wait ...

Andrew Penn, RN, MS, NP, CNS, APRN-BC

Andrew Penn RN, MS, NP, CNS, APRN-BC, UC San Francisco trained psychiatric nurse practitioner. Associate clinical professor in the UCSF School of Nursing, practicing at the San Francisco VA. He has worked as study therapist on a MDMA-assisted therapy protocol for PTSD.


Speaker Disclosures:
Financial: Andrew Penn has employment relationships with UCSF School of Nursing and the San Francisco Veterans Administration Hospital. He receives a consulting fee from Otsuka and Alkermes. Andrew Penn receives a grant from Filament and previously received a grant from Usona. He is a researcher at Texas Tech University and UCSF Langley Porter Institute. Andrew Penn receives a speaking honorarium and recording royalties from PESI, Inc. All relevant financial relationships with ineligible organizations have been mitigated.
Non-financial: Andrew Penn serves on the community advisory board for Filament and Osmind. He is a member of the American Psychiatric Nurses Association. He is an editor for several peer review journals, for a complete list contact PESI, Inc. Andrew Penn is the co-founder of the Organization of Psychedelic and Entheogenic Nurses.

The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and other Mental Distress

Michael Mithoefer, MD |  Rick Doblin, PhD |  Phil Wolfson, MD |  Sue Carter, PhD |  Robin Carhart-Harris, PhD |  Andrew Penn, RN, MS, NP, CNS, APRN-BC |  Richard C. Schwartz, PhD |  Anne Wagner, PhD, C Psych |  ....
3 Hours 59 Minutes
May 18, 2021
Product Code:
Media Type:
Digital Seminar
$99.99 - 2024 Sweet Sale Normal Price: Standard - $199.99

Showing 1 to 2 of 2 entries